-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CIoTLOI2jDakKPTJtiMf8mu16etWkYTl5bT5K8gXWZS+pB84QTD8NGTW4NtFmCfq ZgvzbIhYa4AtIKt2+uKtiA== 0000950130-01-000531.txt : 20010205 0000950130-01-000531.hdr.sgml : 20010205 ACCESSION NUMBER: 0000950130-01-000531 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20010201 ITEM INFORMATION: FILED AS OF DATE: 20010201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BECTON DICKINSON & CO CENTRAL INDEX KEY: 0000010795 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 220760120 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-04802 FILM NUMBER: 1521860 BUSINESS ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417-1880 BUSINESS PHONE: 2018476800 MAIL ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKE STATE: NJ ZIP: 07417 8-K 1 0001.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 1, 2001 ----------------- BECTON, DICKINSON AND COMPANY - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 - -------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer Iden- diction of incorporation) File Number) tification Number) 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (201) 847-6800 -------------- N/A - -------------------------------------------------------------------------------- (Former name or former addresses if changed since last report.) Item 9. Regulation FD Disclosure See the revenue information attached hereto as Exhibit 99, which is incorporated herein by reference. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BECTON, DICKINSON AND COMPANY (Registrant) By: /s/ Richard A. Carbone ----------------------- Richard A. Carbone Assistant Secretary Date: February 1, 2001 - 2 - INDEX TO EXHIBITS ----------------- Exhibit Number Description of Exhibits ------ ----------------------- 99 Revenue Information EX-99 2 0002.txt SUPPLEMENTAL REVENUE INFORMATION BD Fiscal Year 2000 - Year to Date September Revenues by Business Segments and Major Product Groups ($000's)
United States International ---------------------------------------- ------------------------------------------------------- Reported Reported FX Neutral 2000 1999 % Growth 2000 1999 % Growth % Growth --------------------------------------------------------------------------------------------------- Medical Systems Core Medical (A) $ 544,532 $ 521,179 4.5% $ 612,043 $ 603,819 1.4% 4.4% Consumer Health Care 307,082 331,596 -7.4% 198,170 181,309 9.3% 13.5% Pharmaceutical Systems 48,140 41,881 14.9% 206,681 195,975 5.5% 16.1% Ophthalmic Systems 27,601 27,859 -0.9% 21,790 20,247 7.6% 11.7% ---------------------------------------- ---------------------------------------------------- 927,355 922,515 0.5% 1,038,684 1,001,350 3.7% 8.5% Clinical Laboratory Solutions Preanalytical Solutions 291,801 279,497 4.4% 242,991 229,229 6.0% 11.3% Diagnostic Systems 331,689 322,177 3.0% 235,871 230,332 2.4% 4.4% ---------------------------------------- ---------------------------------------------------- 623,490 601,674 3.6% 478,862 459,561 4.2% 7.8% Biosciences Immunocytometry & Reagents 231,793 147,229 57.4% 174,906 151,153 15.7% 22.3% Discovery Labware 80,917 76,367 6.0% 62,327 58,563 6.4% 7.3% ---------------------------------------- ---------------------------------------------------- 312,710 223,596 39.9% 237,233 209,716 13.1% 18.1% ---------------------------------------- ---------------------------------------------------- Total $1,863,555 $1,747,785 6.6% $1,754,779 $1,670,627 5.0% 9.5% ======================================== ==================================================== Total ---------------------------------------------------- Reported FX Neutral 2000 1999 % Growth % Growth ---------------------------------------------------- Medical Systems Core Medical (A) $1,156,575 $1,124,998 2.8% 4.5% Consumer Health Care 505,252 512,905 -1.5% 0.0% Pharmaceutical Systems 254,821 237,856 7.1% 15.9% Ophthalmic Systems 49,391 48,106 2.7% 4.4% ---------------------------------------------------- 1,966,039 1,923,865 2.2% 4.7% Clinical Laboratory Solutions Preanalytical Solutions 534,792 508,726 5.1% 7.5% Diagnostic Systems 567,560 552,509 2.7% 3.5% ---------------------------------------------------- 1,102,352 1,061,235 3.9% 5.5% Biosciences Immunocytometry & Reagents 406,699 298,382 36.3% 39.6% Discovery Labware 143,244 134,930 6.2% 6.6% ---------------------------------------------------- 549,943 433,312 26.9% 29.3% ---------------------------------------------------- Total $3,618,334 $3,418,412 5.8% 8.0% ====================================================
(A) Core Medical includes Injection Systems, Infusion Therapy Systems, Anesthesia Systems, Surgical Products, and Critical Care Systems BD Fiscal Year 2000 - Quarter 4 Revenues by Business Segments and Major Product Groups ($000's)
United States International --------------------------------------- ---------------------------------------------------- Reported Reported FX Neutral 2000 1999 % Growth 2000 1999 % Growth % Growth --------------------------------------- ---------------------------------------------------- Medical Systems Core Medical (A) $ 122,116 $ 133,662 -8.6% $159,072 $155,944 2.0% 5.8% Consumer Health Care 96,239 114,546 -16.0% 46,667 45,473 2.6% 6.8% Pharmaceutical Systems 14,716 10,541 39.6% 51,223 47,519 7.8% 18.4% Ophthalmic Systems 6,252 7,053 -11.4% 5,637 5,048 11.7% 17.2% --------------------------------------- ---------------------------------------------------- 239,323 265,802 -10.0% 262,599 253,984 3.4% 8.6% Clinical Laboratory Solutions Preanalytical Solutions 71,262 71,116 0.2% 59,264 56,623 4.7% 10.6% Diagnostic Systems 78,255 77,843 0.5% 59,159 56,611 4.5% 7.6% --------------------------------------- ---------------------------------------------------- 149,517 148,959 0.4% 118,423 113,234 4.6% 9.1% Biosciences Immunocytometry & Reagents 64,063 44,287 44.7% 48,821 39,245 24.4% 32.9% Discovery Labware 21,053 21,770 -3.3% 16,099 15,199 5.9% 7.8% --------------------------------------- ---------------------------------------------------- 85,116 66,057 28.9% 64,920 54,444 19.2% 25.9% --------------------------------------- ---------------------------------------------------- Total $473,956 $480,818 -1.4% $445,942 $421,662 5.8% 11.0% ======================================= ==================================================== Total --------------------------------------------------- Reported FX Neutral 2000 1999 % Growth % Growth --------------------------------------------------- Medical Systems Core Medical (A) $281,188 $289,606 -2.9% -0.9% Consumer Health Care 142,906 160,019 -10.7% -9.5% Pharmaceutical Systems 65,939 58,060 13.6% 22.3% Ophthalmic Systems 11,889 12,101 -1.8% 0.6% --------------------------------------------------- 501,922 519,786 -3.4% -0.9% Clinical Laboratory Solutions Preanalytical Solutions 130,526 127,739 2.2% 4.8% Diagnostic Systems 137,414 134,454 2.2% 3.5% --------------------------------------------------- 267,940 262,193 2.2% 4.2% Biosciences Immunocytometry & Reagents 112,884 83,532 35.1% 39.1% Discovery Labware 37,152 36,969 0.5% 1.3% --------------------------------------------------- 150,036 120,501 24.5% 27.5% --------------------------------------------------- Total $919,898 $902,480 1.9% 4.4% ===================================================
(A) Core Medical includes Injection Systems, Infusion Therapy Systems, Anesthesia Systems, Surgical Products, and Critical Care Systems BD Fiscal Year 2000 - Year to Date June Revenues by Business Segments and Major Product Groups ($000's)
United States International ---------------------------------------- ---------------------------------------------------- Reported Reported FX Neutral 2000 1999 % Growth 2000 1999 % Growth % Growth ---------------------------------------- ---------------------------------------------------- Medical Systems Core Medical (A) $ 422,416 $ 387,516 9.0% $ 452,971 $ 447,875 1.1% 4.0% Consumer Health Care 210,843 217,050 -2.9% 151,503 135,836 11.5% 15.7% Pharmaceutical Systems 33,424 31,340 6.6% 155,458 148,456 4.7% 15.4% Ophthalmic Systems 21,349 20,806 2.6% 16,153 15,199 6.3% 9.9% ---------------------------------------- ---------------------------------------------------- 688,032 656,712 4.8% 776,085 747,366 3.8% 8.5% Clinical Laboratory Solutions Preanalytical Solutions 220,539 208,382 5.8% 183,727 172,606 6.4% 11.6% Diagnostic Systems 253,434 244,334 3.7% 176,712 173,721 1.7% 3.3% ---------------------------------------- ---------------------------------------------------- 473,973 452,716 4.7% 360,439 346,327 4.1% 7.4% Biosciences Immunocytometry & Reagents 167,730 102,942 62.9% 126,085 111,908 12.7% 18.5% Discovery Labware 59,864 54,597 9.6% 46,228 43,364 6.6% 7.2% ---------------------------------------- ---------------------------------------------------- 227,594 157,539 44.5% 172,313 155,272 11.0% 15.4% ---------------------------------------- ---------------------------------------------------- Total $ 1,389,599 $ 1,266,967 9.7% $ 1,308,837 $ 1,248,965 4.8% 9.1% ======================================== ==================================================== Total ---------------------------------------------------- Reported FX Neutral 2000 1999 % Growth % Growth ---------------------------------------------------- Medical Systems Core Medical (A) $ 875,387 $ 835,391 4.8% 6.3% Consumer Health Care 362,346 352,886 2.7% 4.3% Pharmaceutical Systems 188,882 179,796 5.1% 13.9% Ophthalmic Systems 37,502 36,005 4.2% 5.7% ---------------------------------------------------- 1,464,117 1,404,078 4.3% 6.8% Clinical Laboratory Solutions Preanalytical Solutions 404,266 380,988 6.1% 8.4% Diagnostic Systems 430,146 418,055 2.9% 3.6% ---------------------------------------------------- 834,412 799,043 4.4% 5.9% Biosciences Immunocytometry & Reagents 293,815 214,850 36.8% 39.8% Discovery Labware 106,092 97,961 8.3% 8.6% ---------------------------------------------------- 399,907 312,811 27.8% 30.0% ---------------------------------------------------- Total $ 2,698,436 $ 2,515,932 7.3% 9.4% ====================================================
(A) Core Medical includes Injection Systems, Infusion Therapy Systems, Anesthesia Systems, Surgical Products, and Critical Care Systems Fiscal Year 2000 - Quarter 3 Revenues by Business Segments and Major Product Groups ($000's)
United States International --------------------------------------- ---------------------------------------------------- Reported Reported FX Neutral 2000 1999 % Growth 2000 1999 % Growth % Growth --------------------------------------- ---------------------------------------------------- Medical Systems Core Medical (A) $ 148,834 $ 137,659 8.1% $151,123 $150,550 0.4% 4.2% Consumer Health Care 79,586 80,561 -1.2% 52,092 46,574 11.8% 18.2% Pharmaceutical Systems 13,616 12,055 12.9% 54,085 55,074 -1.8% 10.0% Ophthalmic Systems 7,371 7,371 0.0% 5,475 5,291 3.5% 8.4% --------------------------------------- ---------------------------------------------------- 249,407 237,646 4.9% 262,775 257,489 2.1% 8.1% Clinical Laboratory Solutions Preanalytical Solutions 73,062 75,678 -3.5% 59,576 56,927 4.7% 11.4% Diagnostic Systems 79,961 77,924 2.6% 56,781 57,711 -1.6% 1.4% --------------------------------------- ---------------------------------------------------- 153,023 153,602 -0.4% 116,357 114,638 1.5% 6.3% Biosciences Immunocytometry & Reagents 57,302 38,704 48.1% 38,178 36,803 3.7% 12.0% Discovery Labware 21,669 19,664 10.2% 15,429 14,456 6.7% 9.1% --------------------------------------- ---------------------------------------------------- 78,971 58,368 35.3% 53,607 51,259 4.6% 11.2% --------------------------------------- ---------------------------------------------------- Total $481,401 $449,616 7.1% $432,739 $423,386 2.2% 8.0% ======================================= ==================================================== Total --------------------------------------------------- Reported FX Neutral 2000 1999 % Growth % Growth --------------------------------------------------- Medical Systems Core Medical (A) $299,957 $288,209 4.1% 6.1% Consumer Health Care 131,678 127,135 3.6% 5.9% Pharmaceutical Systems 67,701 67,129 0.9% 10.5% Ophthalmic Systems 12,846 12,662 1.5% 3.5% --------------------------------------------------- 512,182 495,135 3.4% 6.6% Clinical Laboratory Solutions Preanalytical Solutions 132,638 132,605 0.0% 2.9% Diagnostic Systems 136,742 135,635 0.8% 2.1% --------------------------------------------------- 269,380 268,240 0.4% 2.5% Biosciences Immunocytometry & Reagents 95,480 75,507 26.5% 30.5% Discovery Labware 37,098 34,120 8.7% 9.7% --------------------------------------------------- 132,578 109,627 20.9% 24.0% --------------------------------------------------- Total $914,140 $873,002 4.7% 7.5% ===================================================
(A) Core Medical includes Injection Systems, Infusion Therapy Systems, Anesthesia Systems, Surgical Products, and Critical Care Systems Fiscal Year 2000 - Year to Date March Revenues by Business Segments and Major Product Groups ($000's)
United States International ------------------------------------- -------------------------------------------------- Reported Reported FX Neutral 2000 1999 % Growth 2000 1999 % Growth % Growth ------------------------------------- -------------------------------------------------- Medical Systems Core Medical (A) $ 273,582 $ 249,858 9.5% $301,848 $297,325 1.5% 3.8% Consumer Health Care 131,257 136,489 -3.8% 99,411 89,262 11.4% 14.5% Pharmaceutical Systems 19,808 19,285 2.7% 101,373 93,382 8.6% 18.6% Ophthalmic Systems 13,978 13,435 4.0% 10,678 9,908 7.8% 10.7% ------------------------------------- -------------------------------------------------- 438,625 419,067 4.7% 513,310 489,877 4.8% 8.7% Clinical Laboratory Solutions Preanalytical Solutions 147,477 132,703 11.1% 124,151 115,679 7.3% 11.6% Diagnostic Systems 173,473 166,410 4.2% 119,931 116,010 3.4% 4.3% ------------------------------------- -------------------------------------------------- 320,950 299,113 7.3% 244,082 231,689 5.3% 8.0% Biosciences Immunocytometry & Reagents 110,428 64,238 71.9% 87,907 75,105 17.0% 21.8% Discovery Labware 38,195 34,933 9.3% 30,799 28,908 6.5% 6.2% ------------------------------------- -------------------------------------------------- 148,623 99,171 49.9% 118,706 104,013 14.1% 17.5% ------------------------------------- -------------------------------------------------- Total $908,198 $817,351 11.1% $876,098 $825,579 6.1% 9.6% ===================================== ================================================== Total ------------------------------------------------------ Reported FX Neutral 2000 1999 % Growth % Growth ------------------------------------------------------ Medical Systems Core Medical (A) $ 575,430 $ 547,183 5.2% 6.4% Consumer Health Care 230,668 225,751 2.2% 3.4% Pharmaceutical Systems 121,181 112,667 7.6% 15.9% Ophthalmic Systems 24,656 23,343 5.6% 6.9% ------------------------------------------------------ 951,935 908,944 4.7% 6.9% Clinical Laboratory Solutions Preanalytical Solutions 271,628 248,382 9.4% 11.4% Diagnostic Systems 293,404 282,420 3.9% 4.3% ------------------------------------------------------ 565,032 530,802 6.4% 7.6% Biosciences Immunocytometry & Reagents 198,335 139,343 42.3% 44.9% Discovery Labware 68,994 63,841 8.1% 7.9% ------------------------------------------------------ 267,329 203,184 31.6% 33.3% ------------------------------------------------------ Total $ 1,784,296 $ 1,642,930 8.6% 10.4% ======================================================
(A) Core Medical includes Injection Systems, Infusion Therapy Systems, Anesthesia Systems, Surgical Products, and Critical Care Systems Fiscal Year 2000 - Quarter 2 Revenues by Business Segments and Major Product Groups ($000's)
United States International --------------------------------------- ---------------------------------------------------- Reported Reported FX Neutral 2000 1999 % Growth 2000 1999 % Growth % Growth --------------------------------------- ---------------------------------------------------- Medical Systems Core Medical (A) $ 138,673 $ 128,644 7.8% $150,591 $156,622 -3.9% -1.1% Consumer Health Care 75,624 82,118 -7.9% 50,524 45,706 10.5% 15.0% Pharmaceutical Systems 11,190 9,379 19.3% 50,700 49,470 2.5% 12.7% Ophthalmic Systems 6,516 6,301 3.4% 5,511 5,539 -0.5% 3.4% --------------------------------------- ---------------------------------------------------- 232,003 226,442 2.5% 257,326 257,337 0.0% 4.5% Clinical Laboratory Solutions Preanalytical Solutions 78,406 69,372 13.0% 61,080 58,488 4.4% 9.7% Diagnostic Systems 94,021 86,905 8.2% 60,426 61,063 -1.0% 1.0% --------------------------------------- ---------------------------------------------------- 172,427 156,277 10.3% 121,506 119,551 1.6% 5.3% Biosciences Immunocytometry & Reagents 57,100 36,481 56.5% 48,723 43,153 12.9% 18.0% Discovery Labware 20,209 18,918 6.8% 15,838 15,805 0.2% 1.1% --------------------------------------- ---------------------------------------------------- 77,309 55,399 39.5% 64,561 58,958 9.5% 13.5% --------------------------------------- ---------------------------------------------------- Total $481,739 $438,118 10.0% $443,393 $435,846 1.7% 5.9% ======================================= ==================================================== Total --------------------------------------------------- Reported FX Neutral 2000 1999 % Growth % Growth --------------------------------------------------- Medical Systems Core Medical (A) $289,264 $285,266 1.4% 2.9% Consumer Health Care 126,148 127,824 -1.3% 0.3% Pharmaceutical Systems 61,890 58,849 5.2% 13.7% Ophthalmic Systems 12,027 11,840 1.6% 3.4% --------------------------------------------------- 489,329 483,779 1.1% 3.6% Clinical Laboratory Solutions Preanalytical Solutions 139,486 127,860 9.1% 11.5% Diagnostic Systems 154,447 147,968 4.4% 5.2% --------------------------------------------------- 293,933 275,828 6.6% 8.1% Biosciences Immunocytometry & Reagents 105,823 79,634 32.9% 35.7% Discovery Labware 36,047 34,723 3.8% 4.2% --------------------------------------------------- 141,870 114,357 24.1% 26.1% --------------------------------------------------- Total $925,132 $873,964 5.9% 8.0% ===================================================
(A) Core Medical includes Injection Systems, Infusion Therapy Systems, Anesthesia Systems, Surgical Products, and Critical Care Systems BD Fiscal Year 2000 - Quarter 1 Revenues by Business Segments and Major Product Groups ($000's)
United States International --------------------------------------- ---------------------------------------------------- Reported Reported FX Neutral 2000 1999 % Growth 2000 1999 % Growth % Growth --------------------------------------- ---------------------------------------------------- Medical Systems Core Medical (A) $ 134,909 $ 121,214 11.3% $151,257 $140,703 7.5% 9.3% Consumer Health Care 55,633 54,371 2.3% 48,887 43,556 12.2% 14.0% Pharmaceutical Systems 8,618 9,906 -13.0% 50,673 43,912 15.4% 25.3% Ophthalmic Systems 7,462 7,134 4.6% 5,167 4,369 18.3% 19.9% --------------------------------------- ---------------------------------------------------- 206,622 192,625 7.3% 255,984 232,540 10.1% 13.4% Clinical Laboratory Solutions Preanalytical Solutions 69,071 63,331 9.1% 63,071 57,191 10.3% 13.6% Diagnostic Systems 79,452 79,505 -0.1% 59,505 54,947 8.3% 7.9% --------------------------------------- ---------------------------------------------------- 148,523 142,836 4.0% 122,576 112,138 9.3% 10.8% Biosciences Immunocytometry & Reagents 53,328 27,757 92.1% 39,184 31,952 22.6% 26.8% Discovery Labware 17,986 16,015 12.3% 14,961 13,103 14.2% 12.5% --------------------------------------- ---------------------------------------------------- 71,314 43,772 62.9% 54,145 45,055 20.2% 22.6% --------------------------------------- ---------------------------------------------------- Total $426,459 $379,233 12.5% $432,705 $389,733 11.0% 13.7% ======================================= ==================================================== Total --------------------------------------------------- Reported FX Neutral 2000 1999 % Growth % Growth --------------------------------------------------- Medical Systems Core Medical (A) $286,166 $261,917 9.3% 10.2% Consumer Health Care 104,520 97,927 6.7% 7.5% Pharmaceutical Systems 59,291 53,818 10.2% 18.2% Ophthalmic Systems 12,629 11,503 9.8% 10.4% --------------------------------------------------- 462,606 425,165 8.8% 10.6% Clinical Laboratory Solutions Preanalytical Solutions 132,142 120,522 9.6% 11.2% Diagnostic Systems 138,957 134,452 3.4% 3.2% --------------------------------------------------- 271,099 254,974 6.3% 7.0% Biosciences Immunocytometry & Reagents 92,512 59,709 54.9% 57.2% Discovery Labware 32,947 29,118 13.1% 12.4% --------------------------------------------------- 125,459 88,827 41.2% 42.5% --------------------------------------------------- Total $859,164 $768,966 11.7% 13.1% ===================================================
(A) Core Medical includes Injection Systems, Infusion Therapy Systems, Anesthesia Systems, Surgical Products, and Critical Care Systems -----END PRIVACY-ENHANCED MESSAGE-----